Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$3,167.00
Sep 19, 2025
For-profit organization
CIIP PDA – iProgen Biotech Inc. – 2025-26
7471003 P017017001
The purpose of the Canadian International Innovation Program (CIIP) grant agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
$2,225.00
Sep 16, 2025
For-profit organization
CIIP PDA – iProgen Biotech Inc. – 2025-26
7470841 P016998001
The purpose of the Canadian International Innovation Program (CIIP) grant agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
$4,063.00
Aug 13, 2025
For-profit organization
Participation in the Canadian Life Sciences co-innovation mission to Japan - October 2025
1034049
Participation in the Canadian Life Sciences co-innovation mission to Japan October 6 to 10, 2025. Delegation led by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to explore the Japanese market and to develop international partnerships and potential project ideas under the IRAP Japan Program. In Partnership with the Trade Commissioner Service (TCS), and Deep Tech Canada, the Canadian delegation will also receive support for their international business and market-entry strategies, as well as get introductions to other potential partners and clients during the mission.
$5,082.56
Jun 15, 2025
For-profit organization
iProgen Biotech Inc.-2025-2026-1029463
1029463
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
$9,851.25
May 6, 2024
For-profit organization
iProgen Biotech Inc.-2024-2025-1019163
1019163
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
$853,470.00
Mar 1, 2024
For-profit organization
UKRI Biomanufacturing - 10098388 ADC Biocomputer - Development of Automated and Computerized Antibody Drug Conjugate Biomanufacturing Device
1016660
As part of the international consortium project ADC Biocomputer, this project will focus on the development of an advanced, customizable, automated Antibody Drug Conjugate (ADC) biomanufacturing device.
$15,000.00
Jun 9, 2023
For-profit organization
FR-04721
FR-04721
Develop digital adoption plan
$6,288.00
Apr 1, 2023
For-profit organization
iProgen Biotech Inc.-2023-2024-1006163
1006163
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
$12,500.00
Apr 1, 2023
For-profit organization
iProgen Biotech Inc.-2023-2024-1007399
1007399
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
$600,000.00
Dec 1, 2021
For-profit organization
CIIP Korea - Antibody Oligo Drug - Evaluation and Development of antibody conjugated oligos for targeted therapeutics development
984807
This is part of a CIIP Korea project. It will support the firm to generate a series of novel Antibody Oligo Conjugate (AOC) candidates that target lucrative but untapped therapeutic opportunities, by combining two different biotechnologies: 1) Antibody Drug Conjugate and 2) Oligo Therapeutics. The AOC candidates will be evaluated against important multidimensional variables for successful clinical deployment, including biological activity, stability, ease of production and pharmacokinetics.